Chronic kidney disease: Reductions in FGF-23 levels associated with improved outcomes

Nat Rev Nephrol. 2015 Oct;11(10):572-3. doi: 10.1038/nrneph.2015.125. Epub 2015 Jul 28.

Authors

Anna Jovanovich¹, Michel Chonchol²

Affiliations

¹ Renal Section, Medicine Service, Denver VA Medical Center, 1055 Clermont Street, Denver, CO 80220, USA.
² Division of Renal Diseases and Hypertension, University of Colorado Denver Anschutz Medical Center, 13199 East Montview Boulevard, Suite 495, Aurora, CO 80045, USA.

PMID: 26215510
DOI: 10.1038/nrneph.2015.125

No abstract available

Publication types

Comment

MeSH terms

Cardiovascular Diseases / blood*
Cardiovascular Diseases / prevention & control*
Female
Fibroblast Growth Factor-23
Fibroblast Growth Factors / blood*
Humans
Male
Naphthalenes / therapeutic use*
Renal Dialysis*

Substances

FGF23 protein, human
Naphthalenes
Fibroblast Growth Factors
Fibroblast Growth Factor-23